-
Dialogue with a CAR-T Pioneer | Prof. Pei Shanshan and Prof. Michel Sadelain Jointly Depict the Origin, Evolution, and Future Journey of Cellular Therapy
As a revolutionary technology selected among the “Top 10 Global Engineering Achievements of 2024,” CAR-T therapy marks the arrival of the cellular therapy era and brings transformative possibilities to the treatment of cancer and major diseases. During the 2025 International Conference on Cellular and Immune Therapy, a deep dialogue between Prof. Pei Shanshan from Liangzhu Laboratory and…
-
FACO China–Japan Expert Dialogue | Professors Koji Kono, Jin Li, and Xiaotian Zhang Discuss Advances in Precision Treatment for HER2-Positive Gastric Cancer and the Evolving Therapeutic Landscape with T-DXd
China, Japan, and other Asian countries represent the regions with the highest global incidence of gastric cancer. In China, most patients are still diagnosed at advanced stages, losing the opportunity for curative surgery. Effective systemic therapies are therefore critical to improving survival. In recent years, innovative therapies—particularly antibody–drug conjugates (ADCs)—have shown promising results. Among them,…
-
CCHIO 2025丨Professor Tang Feifei: Diagnostic Challenges and Future Breakthroughs in Therapy-Related Myeloid Neoplasms
From November 6–9, 2025, the 2025 China Conference on Holistic Integrative Oncology (CCHIO) was held in Kunming. As one of the most influential oncology conferences in China, CCHIO gathered leading…
-
CCHIO 2025丨Professor Hui Zhou: Advancing Precision Lymphoma Care and System Development—Strategic Planning and Future Directions of the CACA Lymphoma
From November 6–9, 2025, the 2025 China Conference on Holistic Integrative Oncology (CCHIO) was grandly held in Kunming. As one of China’s largest and most influential oncology academic events, the…
Connecting Medical Expertise through Media
